Dev Labtech (543848)
CyclicalScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹95.03 |
| Market Cap | ₹102.47 Cr |
| P/E Ratio | 93.18 |
| ROCE | 5.7% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -29.17% |
| Debt/Equity | — |
| Sales Growth | 152.38% |
| 52-Week Range | ₹13.75 — ₹95.03 |
| Sector | Consumer Durables |
Strengths
- Sales growth of 152.38% shows the company is expanding rapidly in a high-volume segment.
- Latest quarter revenue of ₹49 Cr against a ₹102 Cr market cap implies a meaningful revenue base, not a shell.
- Zero dividend may be acceptable if capital is genuinely being reinvested for growth.
- PEG of 0.61 indicates the market is pricing in a growth re-rating, even if I demand proof.
Concerns
- Profit growth -29.17% and latest quarter net profit ₹0 Cr mean sales growth is not converting to shareholders' earnings.
- P/E of 93.18 leaves no room for anything going wrong at a company that is already earning nearly nothing.
- ROCE of 5.70% is far below what a high-multiple business should deliver on invested capital.
- Piotroski F-score of 4/9 and missing data on book value, debt/equity, and promoter holding reduce transparency.
AI Analysis
When I look at Dev Labtech, I see a small-cap with a big top line and no bottom line. Sales jumped 152.38%, and the latest quarter had ₹49 Cr of revenue. Against a ₹102 Cr market cap, that revenue run-rate looks tempting. But I do not eat revenue; I eat earnings. Profit growth is down 29.17%, and the latest reported net profit is exactly ₹0 Cr. A business that sells a lot and earns nothing is not a business in my book; it is a treadmill. The P/E of 93.18 would be laughable if the market were not serious. Even ROCE of 5.70% tells me that the capital the company does employ is not generating a strong return. Graham would ask where is the margin of safety? At ₹95.03, at the top of a 52-week range of ₹13.75 to ₹95.03, I see no safety, only hope. The Piotroski score of 4 out of 9 adds to my caution; it suggests deteriorating financial health, not a quietly compounding franchise. The PEG of 0.61 is worthless arithmetic when profit growth is negative and the latest quarter's profit is zero. There is no dividend to pay you to wait, and I do not have promoter holding or book value details to form a trust. In gems and jewellery, margins are thin and cycles are unforgiving. A 152% sales jump is not a moat; it is an invitation to study the cost structure. I would rather miss a fast mover than participate in a profitless boom. Let the market have this one; I will wait for evidence that sales can convert into real, repeatable earnings before I commit.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer